Despite the recently reported national decline in opioid overdose deaths, many U.S. communities, including New Orleans, continue to see an ...
Emergent BioSolutions (EBS) announced that it is raising awareness of the Ready to Rescue initiative in New Orleans with pro football legend ...
Papa presented the company’s “turnaround plan” for 2025 at J.P. Morgan. “We are focused on first stabilising the company, then turning it around and ultimately transforming the company,” Papa told the ...
H.C. Wainwright & Co. reaffirmed its Buy rating and $15.00 price target for Emergent BioSolutions stock (NYSE:EBS). The endorsement comes after the company announced a significant contract ...
In the assessment of 12-month price targets, analysts unveil insights for Emergent BioSolutions, presenting an average target of $14.25, a high estimate of $15.00, and a low estimate of $12.00.
Emergent BioSolutions Inc. is a biopharmaceutical company focused on protecting and enhancing life by developing and manufacturing vaccines and antibody therapeutics that are supplied to ...
Emergent BioSolutions (NYSE:EBS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Several other equities ...
(RTTNews) - Emergent BioSolutions (EBS), a life sciences company, on Tuesday announced that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and Canada for ...
GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and ...
Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today tha This option is part of Emergent’s existing 10-year contract with BARDA for advanced development and ...
Emergent BioSolutions Inc. (EBS) stock price is 11.19 and Emergent BioSolutions Inc. (EBS) 10-day simple moving average is 10.22. Emergent BioSolutions Inc. (EBS) stock price is 11.19 and Emergent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results